D-dimer
EstablishedD-dimer is a clot-breakdown product used to rule out venous thromboembolism in low-risk patients.
D-dimer helps rule out dangerous blood clots when combined with a risk score. But the usual cutoff doesn't work well in older adults (it needs age-adjustment) or in pregnant women (where levels are naturally very high), so doctors use different approaches for those groups.
D-dimer is a fibrin degradation product released when blood clots break down, used primarily as a "rule-out" test for venous thromboembolism (deep vein thrombosis and pulmonary embolism) in low-to-moderate risk patients.
A normal D-dimer, combined with low clinical probability (via a validated score like Wells or Geneva), can reasonably exclude pulmonary embolism or DVT without further imaging; an elevated D-dimer is nonspecific and requires imaging confirmation.
Standard cutoffs are unreliable in older adults and pregnant patients. Current European Society of Cardiology guidance recommends an age-adjusted cutoff (age × 10 μg/L for patients over 50) to avoid unnecessary CT scans in older patients, since D-dimer naturally rises with age. In pregnancy, standard cutoffs perform even worse — one study found 99% of pregnant patients exceeded the conventional 0.5 mg/L threshold regardless of clot presence.
In pregnancy, trimester-specific or alternative diagnostic approaches (like the pregnancy-adapted YEARS algorithm) are genuinely needed rather than the standard rule-out threshold, since D-dimer physiologically rises throughout gestation and postpartum.
Requires age-adjusted or pregnancy-specific cutoffs for accurate interpretation in those populations.
- PMC. (2021). Age-Adjusted D-Dimer in the Prediction of Pulmonary Embolism: Systematic Review and Meta-analysis.
- PMC. (2026). D-dimer levels during pregnancy and postpartum: non-applicability of regularly used cut-offs.